These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 11958662

  • 1. Altered expression of G1 regulatory proteins in human soft tissue sarcomas.
    Yoo J, Park SY, Kang SJ, Shim SI, Kim BK.
    Arch Pathol Lab Med; 2002 May; 126(5):567-73. PubMed ID: 11958662
    [Abstract] [Full Text] [Related]

  • 2. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
    Creager AJ, Cohen JA, Geradts J.
    Cancer Detect Prev; 2001 May; 25(2):123-31. PubMed ID: 11341347
    [Abstract] [Full Text] [Related]

  • 3. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.
    Bachmann IM, Straume O, Akslen LA.
    Int J Oncol; 2004 Dec; 25(6):1559-65. PubMed ID: 15547691
    [Abstract] [Full Text] [Related]

  • 4. Combined analysis of p53 and RB pathways in epithelial ovarian cancer.
    Hashiguchi Y, Tsuda H, Yamamoto K, Inoue T, Ishiko O, Ogita S.
    Hum Pathol; 2001 Sep; 32(9):988-96. PubMed ID: 11567230
    [Abstract] [Full Text] [Related]

  • 5. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
    Semczuk A, Miturski R, Skomra D, Jakowicki JA.
    Arch Gynecol Obstet; 2004 Jan; 269(2):104-10. PubMed ID: 14648178
    [Abstract] [Full Text] [Related]

  • 6. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
    Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H.
    Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981
    [Abstract] [Full Text] [Related]

  • 7. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer.
    Kusume T, Tsuda H, Kawabata M, Inoue T, Umesaki N, Suzuki T, Yamamoto K.
    Clin Cancer Res; 1999 Dec; 5(12):4152-7. PubMed ID: 10632354
    [Abstract] [Full Text] [Related]

  • 8. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J.
    Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104
    [Abstract] [Full Text] [Related]

  • 9. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.
    Yao J, Pollock RE, Lang A, Tan M, Pisters PW, Goodrich D, El-Naggar A, Yu D.
    Clin Cancer Res; 1998 Apr 01; 4(4):1065-70. PubMed ID: 9563903
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
    Kanavaros P, Bai M, Stefanaki K, Poussias G, Rontogianni D, Zioga E, Gorgoulis V, Agnantis NJ.
    Histol Histopathol; 2001 Apr 01; 16(2):377-86. PubMed ID: 11332692
    [Abstract] [Full Text] [Related]

  • 11. Aberrant expression of the Rb pathway proteins in soft tissue sarcomas.
    Sabah M, Cummins R, Leader M, Kay E.
    Appl Immunohistochem Mol Morphol; 2006 Dec 01; 14(4):397-403. PubMed ID: 17122635
    [Abstract] [Full Text] [Related]

  • 12. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung.
    Xue Q, Sano T, Kashiwabara K, Saito M, Oyama T, Nakajima T.
    Pathol Int; 2002 Feb 01; 52(2):103-9. PubMed ID: 11940214
    [Abstract] [Full Text] [Related]

  • 13. Early deregulation of the the p16ink4a-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats.
    Fong LY, Nguyen VT, Farber JL, Huebner K, Magee PN.
    Cancer Res; 2000 Aug 15; 60(16):4589-95. PubMed ID: 10969811
    [Abstract] [Full Text] [Related]

  • 14. Analysis of central regulatory pathways in p53-deficient primary cultures of malignant fibrous histiocytoma exposed to ifosfamide.
    Schlott T, Taubert H, Fayyazi A, Schweyer S, Bartel F, Korabiowska M, Brinck U.
    Anticancer Res; 2004 Aug 15; 24(6):3819-29. PubMed ID: 15736417
    [Abstract] [Full Text] [Related]

  • 15. Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma.
    Takahashi Y, Oda Y, Kawaguchi K, Tamiya S, Yamamoto H, Suita S, Tsuneyoshi M.
    Mod Pathol; 2004 Jun 15; 17(6):660-9. PubMed ID: 15098008
    [Abstract] [Full Text] [Related]

  • 16. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
    Skomedal H, Kristensen GB, Lie AK, Holm R.
    Gynecol Oncol; 1999 May 15; 73(2):223-8. PubMed ID: 10329038
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
    Kanavaros P, Stefanaki K, Rontogianni D, Papalazarou D, Sgantzos M, Arvanitis D, Vamvouka C, Gorgoulis V, Siatitsas I, Agnantis NJ, Bai M.
    Histol Histopathol; 2001 Oct 15; 16(4):1005-12. PubMed ID: 11642719
    [Abstract] [Full Text] [Related]

  • 18. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm.
    Tsuda H, Hashiguchi Y, Nishimura S, Kawamura N, Inoue T, Yamamoto K.
    Gynecol Oncol; 2003 Dec 15; 91(3):476-85. PubMed ID: 14675665
    [Abstract] [Full Text] [Related]

  • 19. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
    Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C.
    Am J Pathol; 1998 Dec 15; 153(6):1749-65. PubMed ID: 9846966
    [Abstract] [Full Text] [Related]

  • 20. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J.
    Mol Cell Biol; 1995 May 15; 15(5):2600-11. PubMed ID: 7739541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.